Which should be given first, DPP-4 inhibitor or SGLT2 inhibitor, in combination therapy of these two anti-diabetic drugs?
Not Applicable
Recruiting
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000038377
- Lead Sponsor
- Dokkyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1)type 1 diabetes 2)patients with severe renal dysfunction (eGFR < 30 ml/min/1.73m2) 3)patients with liver dysfunction (hepatic enzymes more than three times the upper limit of normal ranges) 4)a pregnant woman and/or a woman under breast-feeding 5)patients who have diabetic proliferative retinopathy. 6)patients who have an anamnesis of hypersensitivity to the ingredient of a trial drugs. 7)patients who reciving GLP-1 recepter agonist. 8)patients who thought to be inappropriate to enter this study for some medical reasons by physician's judgments.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method